A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin

Completed

Conditions studied: Ocular Hypertension

In brief

Patient charts will be reviewed to evaluate the incidence of intraocular pressure spikes while on Loteprednol etabonate ophthalmic suspension 0.5%, Loteprednol etabonate (0.5%) and tobramycin (0.3%)

Key facts

Study ID

NCT00834171

Run by

Allergan

People needed

50

Starts

2009-01-01

Expected to finish

2009-12-01

Last updated by the study team

2011-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any patient who experienced an IOP spike while using Lotemax or Zylet will be included

You may not qualify if…

• N/A

Where it is running

• Study site — Maclean, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.